These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21674758)

  • 1. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
    Grace RF; Bennett CM; Ritchey AK; Jeng M; Thornburg CD; Lambert MP; Neier M; Recht M; Kumar M; Blanchette V; Klaassen RJ; Buchanan GR; Kurth MH; Nugent DJ; Thompson AA; Stine K; Kalish LA; Neufeld EJ
    Pediatr Blood Cancer; 2012 Feb; 58(2):221-5. PubMed ID: 21674758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab.
    Matsubara K; Takahashi Y; Hayakawa A; Tanaka F; Nakadate H; Sakai M; Maeda N; Oka T; Ishii E; Bessho F; Morimoto T; Goto H; Hashii Y; Hatakeyama N; Shirahata A; Imaizumi M
    Int J Hematol; 2014 Apr; 99(4):429-36. PubMed ID: 24609717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
    Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
    Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia-associated refractory immune thrombocytopenia successfully treated with eltrombopag.
    Chang H; Shih LY
    Tumori; 2015 Apr; 101(2):e49-50. PubMed ID: 25702666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center.
    Jaime-Pérez JC; Aguilar-Calderón P; Jiménez-Castillo RA; Ramos-Dávila EM; Salazar-Cavazos L; Gómez-Almaguer D
    Ann Hematol; 2020 Nov; 99(11):2513-2520. PubMed ID: 32945941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Hegde UP; Wilson WH; White T; Cheson BD
    Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of low-dose rituximab combined with different dosage of glucocorticoids for immune thrombocytopenia].
    Xing WW; Li ZY; Yan ZL; Liu KG; Li N; Cao J; Pan XY; He XP; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):409-12. PubMed ID: 23688751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for children with immune thrombocytopenia: a systematic review.
    Liang Y; Zhang L; Gao J; Hu D; Ai Y
    PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood immune thrombocytopenia: a changing therapeutic landscape.
    Breakey VR; Blanchette VS
    Semin Thromb Hemost; 2011 Oct; 37(7):745-55. PubMed ID: 22187397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population.
    Grace RF; Long M; Kalish LA; Neufeld EJ
    Pediatr Blood Cancer; 2012 Feb; 58(2):216-20. PubMed ID: 21674757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
    Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
    Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.
    Gobert D; Bussel JB; Cunningham-Rundles C; Galicier L; Dechartres A; Berezne A; Bonnotte B; DeRevel T; Auzary C; Jaussaud R; Larroche C; LeQuellec A; Ruivard M; Seve P; Smail A; Viallard JF; Godeau B; Hermine O; Michel M
    Br J Haematol; 2011 Nov; 155(4):498-508. PubMed ID: 21981575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).
    Basciano PA; Bussel J; Hafeez Z; Christos PJ; Giannakakou P
    Br J Haematol; 2013 Jan; 160(2):237-43. PubMed ID: 23157319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.
    Lu KH; George JN; Vesely SK; Terrell DR
    Am J Med Sci; 2014 Mar; 347(3):190-4. PubMed ID: 23462246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
    Patel VL; Mahévas M; Lee SY; Stasi R; Cunningham-Rundles S; Godeau B; Kanter J; Neufeld E; Taube T; Ramenghi U; Shenoy S; Ward MJ; Mihatov N; Patel VL; Bierling P; Lesser M; Cooper N; Bussel JB
    Blood; 2012 Jun; 119(25):5989-95. PubMed ID: 22566601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.